JOLNU Trademark

Trademark Overview

On Wednesday, July 25, 2012, a trademark application was filed for JOLNU with the United States Patent and Trademark Office. The USPTO has given the JOLNU trademark a serial number of 85686118. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 21, 2016. This trademark is owned by Glaxo Group Limited. The JOLNU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jolnu

General Information

Serial Number85686118
Word MarkJOLNU
Filing DateWednesday, July 25, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 21, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 31, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 21, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 21, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2015EXTENSION 5 GRANTED
Tuesday, June 30, 2015EXTENSION 5 FILED
Tuesday, June 30, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 22, 2015EXTENSION 4 GRANTED
Friday, January 16, 2015EXTENSION 4 FILED
Friday, January 16, 2015TEAS EXTENSION RECEIVED
Friday, July 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 17, 2014EXTENSION 3 GRANTED
Monday, July 14, 2014EXTENSION 3 FILED
Monday, July 14, 2014TEAS EXTENSION RECEIVED
Wednesday, March 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 4, 2014EXTENSION 2 GRANTED
Monday, February 17, 2014EXTENSION 2 FILED
Sunday, March 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Friday, August 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2013EXTENSION 1 GRANTED
Wednesday, August 14, 2013EXTENSION 1 FILED
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 19, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 11, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 28, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

jolnu pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological